Patients begin to lose weight, often seeing steady, sustainable fat reduction. Increased satiety and appetite regulation, helping control food intake. Improved insulin sensitivity, reducing the need for additional diabetes medications
Muto, S
The most immediate change is that the supplemental supply in your bloodstream starts to drop
Not all peptides act alike, and understanding their biological tone - whether they promote or restrain blood vessel growth - is key when evaluating safety for each patient
While its effective for blood sugar control, its weight loss results are modest compared to newer options
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007